ロード中...
Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
The main treatments for patients with nonalcoholic fatty liver disease (NAFLD) are currently based on lifestyle changes, including ponderal decrease and dietary management. However, a subgroup of patients with nonalcoholic steatohepatitis (NASH), who are unable to modify their lifestyle successfully...
保存先:
| 出版年: | Pharmaceuticals (Basel) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6315965/ https://ncbi.nlm.nih.gov/pubmed/30314377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph11040104 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|